Form 8-K - Current report:
SEC Accession No. 0000950170-25-027721
Filing Date
2025-02-26
Accepted
2025-02-26 16:07:08
Documents
13
Period of Report
2025-02-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mnkd-20250226.htm   iXBRL 8-K 41658
2 EX-99.1 mnkd-ex99_1.htm EX-99.1 581066
3 GRAPHIC img208524907_0.jpg GRAPHIC 27559
  Complete submission text file 0000950170-25-027721.txt   800397

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mnkd-20250226.xsd EX-101.SCH 25053
15 EXTRACTED XBRL INSTANCE DOCUMENT mnkd-20250226_htm.xml XML 4733
Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50865 | Film No.: 25670007
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)